Characteristics of radiolabelled versus unlabelled inhaler formulations

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Newman, S P ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

Author keywords

Gamma scintigraphy; Metered dose inhaler; Powder inhaler; Radiolabel

Indexed keywords

CARBON 14; CROMOGLYCATE DISODIUM; ORCIPRENALINE; SALBUTAMOL; TECHNETIUM 99M; TERBUTALINE SULFATE;

AEROSOL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; GAMMA SCINTIGRAPHY; INHALATIONAL DRUG ADMINISTRATION; ISOTOPE LABELING; PARTICLE SIZE; PHARMACEUTICS; PHARMACOKINETICS;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; ANTI-ASTHMATIC AGENTS; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; CROMOLYN SODIUM; HUMANS; ISOTOPE LABELING; NEBULIZERS AND VAPORIZERS; ORCIPRENALINE; TECHNETIUM;

EID: 0029935248     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.suppl_1.s-37     Document Type: Article

References (22)

1. ARPPE, J. and VIDGREN, M. (1994) Practical gamma labelling method for metereddose inhalers and inhalation powders. S.T.P. Pharm Sci. 4, 19-22.
2. AUG, C., PERRY, R.J. and SMALDONE, G.G. (1991). Technetium-99m radiolabeling of aerosolized drug particles from metered dose inhalers. J. Aerosol Med. 4, 127.
3. BIDDISCOMBE, M.F., MELCHOR, R., MAK, V.H.F., MARRIOTT, R.J., TAYLOR, A.J., SHORT, M.D. and SPIRO, S.G. (1993) The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurised metered dose and dry powder inhalers. Int. J. Pharm. 91, 111-121.
4. BIDLINGMAIER, A., WAITZINGER, J., HAMMERMAIER, A., FLEISCHER, W. and JAEGER, H. (1993). Radiolabelling of a corticosteroid with Tc-99m and lung deposition after released from a metered dose inhaler. J. Aerosol Med. 6, Supplement, 43.
5. CLARKE, J.G., FARR, S.J. and WICKS, S.R. (1992). Technetium-99m labelling of suspension type pressurised metered dose inhalers comprising various drug / surfactant combinations. Int. J. Pharm. 80, R1-R5.
6. DASHE, C.K., PONTO, R.A., GANAPES, C.M., DRAGE, C.W. and KRONENBERG, R.S. (1974). The distribution of nebulised isoproterenol and its effect on regional ventilation and perfusion. Am. Rev. Respir. Dis. 110, 293-300.
7. DOLOVICH, M.B., RUFFIN, R.E., ROBERTS, R. and NEWHOUSE, M.T. (1981). Optimal delivery of aerosols from metered dose inhalers. Chest 80, Supplement, 911-915.
8. DOLOVICH, M.B., CHAMBERS, C., GERRARD, L. and NEWHOUSE, M.T. (1991). Distribution of drug and label in radiolabelled procaterol aerosol. J. Aerosol Med. 4, 8.
9. JAEGFELDT, H., ANDERSEN, J.A.R., TROFAST, E. and WETTERLIN, K. (1987). Particle size distribution from different modifications of Turbuhaler. In: A new concept in inhalation therapy (Eds., Newman, S.P., Morén, F. and Crompton, G.K.). Medicom, Bussum, pp. 90-99.
10. KÖHLER, D., FLEISCHER, W. and MATTHYS, H. (1988). A new method for easy labelling of beta-2 agonists in the metered dose inhaler with Tc-99m. Respiration 53, 65-73.
11. MALTON, C.A. (1982). University of Nottingham Ph.D. Thesis.
12. MALTON, C.A., HALLWORTH, G.W. and PADFIELD, J.M. (1982). The association and particle size distribution of drug and surfactant discharged from a metered dose inhalation aerosol. J. Pharm. Pharmacol. 34, 65P.
13. MELCHOR, R., BIDDISCOMBE, M.F., MAK, V.H.F., SHORT, M.D. and SPIRO, S.G. (1993) Lung deposition of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 48, 506-511.
14. NEWMAN, S.P., PAVIA, D., MOREN, F., SHEAHAN, N.F. and CLARKE, S.W. (1981). Deposition of pressurised aerosols in the human respiratory tract. Thorax 36, 52-55.
15. NEWMAN, S.P., CLARK, A.R., TALAEE, N. and CLARKE, S.W. (1989a). Pressurised aerosol deposition in the human lung with and without an "open" spacer. Thorax 44, 706-710.
16. NEWMAN, S.P., MORÉN, F., TROFAST, E., TALAEE, N. and CLARKE, S.W. (1989b). Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multidose powder inhaler. Eur. Respir. J. 2, 247-252.
17. NEWMAN, S.P., WEISZ, A.W.B., TALAEE, N. and CLARKE, S.W. (1991). Improvement of drug delivery with a breath-actuated pressurised aerosol for patients with poor inhaler technique. Thorax 46, 712-716.
18. RUFFIN, R.E., DOLOVICH, M.B., WOLFF, R.K. and NEWHOUSE, M.T. (1978). The effects of preferential deposition of histamine in the human airway. Am. Rev. Respir. Dis. 117, 485-492.
19. SPIRO, S.G., SINGH, C.A., TOLFREE, S.E.J., PARTRIDGE, M.R. and SHORT, M.D. (1984). Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis. Thorax 39, 432-435.
20. SUMMERS, Q.A., CLARK, A.R., HOLLINGWORTH, A., FLEMING, J. and HOLGATE, S.T. (1990). The preparation of a radiolabelled aerosol of nedocromil sodium for administration by metered dose inhaler that accurately preserves particle size distribution of the drug. Drug Invest. 2, 90-98.
21. VIDGREN M., KARKKAINEN, A., KARJALAINEN, P. and PARONEN, P. (1987). A novel method for measuring the deposition of drug particles in the respiratory tract. Int. J. Pharm. 37, 239-244.
22. ZAINUDIN, B.M.Z., BIDDISCOMBE, M., TOLFREE, S.E.J., SHORT, M. and SPIRO, S.G. (1990). Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 45, 469-473.